HCV Coinfection Completed Phase 4 Trials for Fosamprenavir (DB01319)

Also known as: Hepatitis (non-A non-B) / Viral hepatitis C / Hepatitis non-A non-B / Non-A non-B hepatitis / Hepatitis C / Unspecified viral hepatitis C / Hep non-A non-B

IndicationStatusPhase
DBCOND0048683 (HCV Coinfection)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01222611HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With FosamprenavirTreatment